T
Originally published by The Standard BusinessMay 6, 2026
3h ago
Germany firm BioNTech to cut up to 1,860 jobs as Covid jab sales drop

The biotech company plans to stop operating at three manufacturing sites in Germany by the end of 2027..
✨ Key Highlights
Germany's BioNTech plans to cut up to 1,860 jobs and close several manufacturing sites by the end of 2027 as sales of its COVID-19 vaccine decline.
- Up to 1,860 jobs are affected by the planned closure of manufacturing sites in Germany and Singapore.
- The company, best known for its COVID-19 vaccine developed with Pfizer, reported a 35% drop in sales to €118.1 million.
- BioNTech anticipates lower COVID-19 vaccine revenues in 2026 compared to 2025.
Continue Reading
Read the complete article from The Standard Business
Advertisement
Related News
Advertisement

